Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.39 -0.05 (-3.47%)
As of: Nov 11, 2026 · 11:03 AM EST

Cadrenal Therapeutics (CVKD) EBIT (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) recorded EBIT of -$3.34 million in Q2 2026, compared with -$3.73 million a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) EBIT (2022 - 2026) Analysis & Trends

On a TTM basis, Cadrenal Therapeutics' EBIT came in at -$12 million as of Jun 30, 2026; for FY2023, it was -$7.63 million.

  • Across earlier years, EBIT came in at -$2.7 million in FY2022.
  • The Q2 2026 figure is the highest quarterly EBIT since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.27 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.39 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.46 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.47 Bn
10 Cadrenal Therapeutics 557,746.58 -12.06 Mn - -3.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.34 Mn
Mar 31, 2026 -2.51 Mn
Dec 31, 2025 -3.07 Mn
Sep 30, 2025 -2.73 Mn
Jun 30, 2025 -3.73 Mn
Mar 31, 2025 -3.93 Mn
Dec 31, 2024 -4.28 Mn
Sep 30, 2024 -2.46 Mn
Jun 30, 2024 -2.47 Mn
Mar 31, 2024 -1.76 Mn
Dec 31, 2023 -1.26 Mn
Sep 30, 2023 -1.14 Mn
Jun 30, 2023 -1.03 Mn
Mar 31, 2023 -4.20 Mn
Dec 31, 2022 -1.08 Mn
Sep 30, 2022 -972,791.00
Jun 30, 2022 -482,347.00
Mar 31, 2022 -170,521.00
API Access

Cadrenal Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=CVKD&period=max&api_key=YOUR_API_KEY